We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Tool Outperforms Human Pathologists in Predicting Survival after Colorectal Cancer Diagnosis

By HospiMedica International staff writers
Posted on 14 Apr 2023
Print article
Image: AI tool predicts colon cancer survival and treatment response (Photo courtesy of Freepik)
Image: AI tool predicts colon cancer survival and treatment response (Photo courtesy of Freepik)

Colorectal cancer, the second most lethal cancer worldwide, exhibits varying behavior even among individuals with similar disease profiles who undergo the same treatment. Now, a new artificial intelligence (AI) model may now offer valuable insight to doctors making prognoses and determining treatments for patients with colorectal cancer.

Researchers at Harvard Medical School (Boston, MA, USA) and National Cheng Kung University (Tainan, Taiwan) have developed a tool called MOMA (Multi-omics Multi-cohort Assessment) that accurately predicts colorectal tumor aggressiveness, patient survival rates with and without disease recurrence, and the most effective therapy by analyzing tumor sample images alone. Unlike many existing AI tools that primarily replicate or optimize human expertise, MOMA identifies and interprets visual patterns on microscopy images that are undetectable to the human eye. The tool is freely available to researchers and clinicians.

The model was trained using data from approximately 2,000 colorectal cancer patients from diverse national patient cohorts, totaling over 450,000 participants. During training, researchers provided the model with information about patients' age, sex, cancer stage, and outcomes, as well as genomic, epigenetic, protein, and metabolic profiles of the tumors. The model was then tasked with identifying visual markers related to tumor types, genetic mutations, epigenetic changes, disease progression, and patient survival using pathology images of tumor samples. The model's performance was assessed using a set of previously unseen tumor sample images from different patients, comparing its predictions to actual patient outcomes and other clinical data.

MOMA accurately predicted overall survival following diagnosis and the number of cancer-free years for patients. It also correctly anticipated individual patient responses to various therapies based on the presence of specific genetic mutations influencing cancer progression or spread. In both areas, the tool outperformed human pathologists and current AI models. The researchers recommend testing the model in a prospective, randomized trial evaluating its performance in real patients over time after initial diagnosis before deploying it in clinics and hospitals. Such a study would directly compare MOMA's real-life performance using only images with human clinicians who utilize additional knowledge and test results unavailable to the model, providing the gold-standard demonstration of its capabilities.

“Our model performs tasks that human pathologists cannot do based on image viewing alone,” said study co-senior author Kun-Hsing Yu, assistant professor of biomedical informatics in the Blavatnik Institute at Harvard Medical School, who led an international team of pathologists, oncologists, biomedical informaticians, and computer scientists. “What we anticipate is not a replacement of human pathology expertise, but augmentation of what human pathologists can do. We fully expect that this approach will augment the current clinical practice of cancer management.”

Related Links:
Harvard Medical School
National Cheng Kung University

Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
New
Silver Supplier
Patient Simulator
PatSim 200
New
Abdominal Stent Graft Platform
Ovation iX
New
Digital X-Ray Flat Panel Detector
2121DXV

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: Chest e-tattoo boasts major improvements in heart monitoring (Photo courtesy of UT)

Chest E-Tattoo for Continuous, Mobile Heart Monitoring Could Catch Cardiovascular Diseases Early

Most heart-related ailments are insidious in nature, damaging health quietly and unnoticed. Continuous, at-home mobile monitoring can lead to early diagnosis and treatment, potentially preventing up to... Read more

Surgical Techniques

view channel
Image: RefluxStop treats acid reflux without affecting the food passageway (Photo courtesy of Implantica AG)

Breakthrough Implant Marks Paradigm Shift in Treatment of Gastroesophageal Reflux

Acid reflux, a condition characterized by the regurgitation of the stomach's acid content into the esophagus, affects approximately 400 million individuals daily, making it the second-largest treatment... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)

Next Gen Viscoelastic Coagulation Monitor Enables Rapid Hemostasis Assessment at Patient Side

The use of viscoelastic coagulation testing is on the rise for various applications such as trauma, surgery, obstetrics, major disease management, and more. It provides crucial information not obtained... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.